TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

AHKSY

Asahi Kaisei Corp

PINKCommon Stock
$22.03
-1.61%today

No SEC filings for this security

Asahi Kaisei Corp is a foreign or OTC-listed security (PINK) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$12.82 – $23.34
12.8252-week23.34
Market cap
$14.9B
Volume
1.82K
1Y return
+62.41%
Beta
0.65

Price · 1Y

$22.03▲ +62.41%
over 1Y
L $12.82H $23.34

Recent news

market news →
Asahi Kasei’s Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing TimeBullish
finance.yahoo.com· 2026-06-25
Veloxis Pharmaceuticals Showcases Research at the 2026 American Transplant CongressBullish
finance.yahoo.com· 2026-06-17
EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei’s Novel Electrolyte Acetolyte™Bullish
finance.yahoo.com· 2026-06-02
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer TreatmentsBullish
finance.yahoo.com· 2026-05-27
[Latest] Global Specialty Chemicals Market Size/Share Worth USD 1497 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Bullish
finance.yahoo.com· 2026-05-26
Assessing Asahi Kasei (TSE:3407) Valuation After Recent Share Price StrengthBullish
finance.yahoo.com· 2026-05-24
Japan Specialty Chemicals Market Outlook 2026-2036: Expansion Driven by Growing Demand for Application-specific Chemical Inputs in the Pharmaceutical SectorBullish
finance.yahoo.com· 2026-05-21
Asahi Kasei Develops Novel Photosensitive Polyimide Film for Advanced Panel-Level Semiconductor PackagingBullish
finance.yahoo.com· 2026-05-21

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.